Cytokinetics reported $-10874000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -33651000 79.36M
Acorda Therapeutics ACOR:US $ -13890000 387K
Amgen AMGN:US $ 2176M 324M
Arca Biopharma ABIO:US $ -5680000 1.58M
Bayer BAYN:GR 2.28B 1.89B
Biogen BIIB:US $ 940.9M 409.4M
Bristol Myers Squibb BMY:US $ 3197M 9M
Cytokinetics CYTK:US $ -10874000 66.98M
Eisai 4523:JP 7.43B 28.23B
Eli Lilly And LLY:US $ 1650.5M 919.4M
Exelixis EXEL:US $ 83.71M 463K
Genocea Biosciences GNCA:US $ -15773000 2.36M
Geron GERN:US $ -27976000 699K
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Intra Cellular Therapies ITCI:US $ -87923000 15.26M
Merk MRK:US $ 5711M 652M
Novartis NOVN:VX 3.32B 176M
Pfizer PFE:US $ 12099M 2104M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M